International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-5 doi: https://doi.org/10.5281/zenodo.13903236
Original Research Article
Prospective Study on Postoperative Complications and Recovery in Patients Undergoing Laparoscopic vs. Open Cholecystectomy
Published
Oct. 8, 2024
Abstract

Background: Laparoscopic cholecystectomy (LC) has largely replaced open cholecystectomy (OC) as the standard surgical treatment for symptomatic gallstone disease. However, there is ongoing debate regarding the differences in postoperative complications and recovery outcomes between these two approaches. Objective: To compare the postoperative complications and recovery outcomes between LC and OC in patients with symptomatic gallstone disease. Methods: This prospective, randomized study included 120 patients with symptomatic gallstone disease who were allocated to either the LC (n=60) or OC (n=60) group. Intraoperative outcomes, postoperative complications, pain scores, recovery measures, and quality of life scores (SF-36) were assessed. Results: LC was associated with significantly shorter operative time (62.5 ± 15.6 min vs. 78.3 ± 18.2 min, p<0.001), lower blood loss (20 mL vs. 40 mL, p<0.001), and a lower incidence of wound infection (3.3% vs. 13.3%, p=0.048) compared to OC. Patients in the LC group had significantly lower postoperative pain scores (p<0.001), shorter hospital stay (median: 2 days vs. 4 days, p<0.001), and earlier return to normal activities (median: 10 days vs. 18 days, p<0.001). Quality of life scores were significantly higher in the LC group at 1 and 3 months (p<0.05). The surgical approach was a significant predictor of postoperative complications (OR: 3.12, 95% CI: 1.02- 9.58, p=0.047) and prolonged hospital stay (OR: 5.04, 95% CI: 1.96-12.95, p=0.001), favoring LC over OC. Conclusion: LC is associated with better intraoperative outcomes, fewer postoperative complications, faster recovery, and improved quality of life compared to OC in patients with symptomatic gallstone disease. These findings support the current recommendations favoring LC as the gold standard for the surgical management of gallstone disease

Recommended Articles
Loading Image...
Volume-5, Issue-5
Citations
2412 Views
497 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved